This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB6U08A_M.jpg
Merck&Co announced earnings per share of $1.37 on revenue of $10.87B. Analysts polled by Investing.com anticipated EPS of $1.06 on revenue of $10.38B.
Merck&Co shares are down 13% from the beginning of the year , still down 14.73% from its 52 week high of $92.64 set on December 20, 2019. They are under-performing the S&P 500 which is up 0.48% from the start of the year.
Merck&Co’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
